Activin Inhibits the Human Pit-1 Gene Promoter through the p38 Kinase Pathway in a Smad-Independent Manner

Author:

de Guise Chantal1,Lacerte Annie1,Rafiei Shahrzad1,Reynaud Rachel12,Roy Melanie1,Brue Thierry2,Lebrun Jean-Jacques1

Affiliation:

1. Hormones and Cancer Research Unit (C.d.G., A.L., S.R., R.R., M.R., J.-J.L.), Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada H3A 1A1

2. Department of Endocrinology (R.R., T.B.), Hopital de la Timone, 13005 Marseille, France

Abstract

The pituitary transcription factor Pit-1 regulates hormonal production from the anterior pituitary gland. However, the mechanisms by which Pit-1 gene expression is regulated in humans are poorly understood. Activin, a member of the TGFβ superfamily, acts as a negative regulator of cell growth and prolactin gene expression in lactotrope cells. In this study, we show that activin negatively regulates the human Pit-1 gene promoter. We defined a 117-bp element within the Pit-1 promoter that is sufficient to relay these inhibitory effects. We further investigated the signaling pathways that mediate activin-induced inhibition of Pit-1 gene promoter in pituitary lactotrope cells. We found that the activin effects on Pit-1 gene regulation are Smad independent and require the p38 MAPK pathway. Specifically, blocking p38 kinase activity reverses activin-mediated inhibition of the Pit-1 gene promoter. Together, our results highlight the p38 MAPK pathway as a key regulator of activin function in pituitary lactotrope cells and further emphasizes the critical role played by activin in regulating hormonal production in the pituitary gland.

Publisher

The Endocrine Society

Subject

Endocrinology

Reference45 articles.

1. Molecular targets in pituitary tumours;Heaney;Nat Rev Cancer,2004

2. Dopamine as a prolactin (PRL) inhibitor;Ben-Jonathan;Endocr Rev,2001

3. The cytogenesis and pathogenesis of pituitary adenomas;Asa;Endocr Rev,1998

4. Dopamine receptors: from structure to function;Missale;Physiol Rev,1998

5. Cabergoline: an advance in dopaminergic therapy;Bevan;Clin Endocrinol (Oxf),1994

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3